General Motors Investment Management’s Charles River Laboratories CRL Stock Holding History

General Motors Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-9,720	Closed	-$771K	–	139
2015 Q1	$771K	Buy	+9,720	New	+$717K	0.07%	292
2014 Q4	–	Sell	-15,063	Closed	-$900K	–	931
2014 Q3	$900K	Buy	+15,063	New	+$862K	0.07%	292
2014 Q2	–	Sell	-13,993	Closed	-$844K	–	949
2014 Q1	$844K	Buy	+13,993	New	+$816K	0.07%	309
2013 Q4	–	Sell	-18,195	Closed	-$842K	–	953
2013 Q3	$842K	Buy	+18,195	New	+$835K	0.07%	325

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

General Motors Investment Management's CRL Position: Q2 2015 in Review

General Motors Investment Management sold out of Charles River Laboratories (CRL) in Q2 2015, closing a stake of 9,720 shares — an estimated $771K sold.

General Motors Investment Management first reported a position in CRL in Q3 2013 and held it in 4 quarters. The position peaked at $900K in Q3 2014. 261 funds tracked by Wall St. Rank hold CRL as of Q2 2015.

General Motors Investment Management reported no remaining Charles River Laboratories position as of Q2 2015 after selling out during the quarter.
General Motors Investment Management sold 9,720 Charles River Laboratories shares in Q2 2015, an estimated $771K.
General Motors Investment Management first reported a position in Charles River Laboratories in Q3 2013 and held it in 4 quarters.
General Motors Investment Management's Charles River Laboratories position peaked at $900K in Q3 2014.
261 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.